Spun out of Queensland and Emory universities, the biotech developer has secured capital from Uniseed and the Medical Research Commercialisation Fund.
Que Oncology, a biotechnology producer based on research conducted at University of Queensland and Emory University, secured $16m in a series A round yesterday from backers including commercialisation firm Uniseed.
The Medical Research Commercialisation Fund also participated in the round. The fund, backed by Australia’s government and several domestic pension funds, focuses on the commercialisation and early-stage development of technologies emerging from Australian medical research institutes and affiliated research hospitals.
Founded in 2013, Que Oncology is working on a range…
